RPTH Journal/LinkedIn
Nov 9, 2025, 10:18
RPTH Study Finds 3× Cancer Risk in Migraine Patients After VTE
RPTH Journal posted on LinkedIn:
”Patients with migraines have a higher risk of venous clots.
Oscar Rosenkrantz and team examined if cancer risk after clot was still elevated. They found in a Danish cohort that risk was 3x higher in year one vs expected rates, suggesting occult cancer may still explain clots.
Read the study here.
Title: Venous thromboembolism and cancer risk in patients with a history of migraine: a population-based cohort study
Authors: Oscar Rosenkrantz, Dóra K. Farkas, Erzsébet Horváth-Puhó, Søren K. Martiny, Holly Elser, Cecilia H. Fuglsang, Henrik T. Sørensen”
Stay updated with Hemostasis Today.
Blood Clots
cancer
Cancer Risk
Cecilia H. Fuglsang
Dóra K. Farkas
Erzsébet Horváth-Puhó
Health
Hematology
Hemostasis
Hemostasis Today
Henrik T. Sørensen
Holly Elser
International Society on Thrombosis and Haemostasis
ISTH
Medicine
Migraine
Oscar Rosenkrantz
rpth
RPTH Journal
Søren K. Martiny
thrombosis
venous thromboembolism
-
Apr 11, 2026, 13:51David McIntosh: Vital Plasma Derived Medicines – The Anomalous UK Scene
-
Apr 11, 2026, 13:47Samrawit Terefe: O Negative Blood Is the Universal Donor With Extreme Scarcity
-
Apr 11, 2026, 13:39Dheeraj Garg: Rethinking Cardiovascular Disease – A Cardiologist’s Perspective
-
Apr 11, 2026, 13:37Kushal Bhatia: Is The 4.5-Hour Thrombolysis Window Officially Outdated?
-
Apr 11, 2026, 13:35William Aird: Why Did Mammalian Red Blood Cells Give Up Their Nucleus?
-
Apr 11, 2026, 13:30Ken Kuang: Gravity Is Constant, But Your Vein Health Doesn’t Have to Be
-
Apr 11, 2026, 13:21Mascha Kern: Measuring Gender’s Role in Stroke and Migraine
-
Apr 11, 2026, 13:10Danique Steeghs: Key Findings from a Microfluidic Chemiluminescent Thrombin Generation Assay
-
Apr 11, 2026, 13:06Shanvi Mahi: A Validated Tool to Explore Lived Experiences After Stroke Rehabilitation